MB "NorthSpeed Biotech" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 214,769 |
| - |
| 32,672 |
| 31,038 |
| - |
| 18.77 |
| 14.45 |
| 38,021 |
| 16,594 |
| 5,000 |
| 49,615 |
| 2024 |
|---|
| 331,392 |
| - |
| 68,091 |
| 59,168 |
| - |
| 29.21 |
| 17.85 |
| 59,947 |
| 18,114 |
| 8,835 |
| 69,226 |
| 2025 |
|---|
| 430,444 |
| 430,444 |
| 88,585 |
| 75,652 |
| 75,652 |
| 28.78 |
| 17.58 |
| 95,884 |
| 23,717 |
| 11,234 |
| 108,367 |
Register and
explore Okredo data| 2025 |
|---|
| 430,444 |
| 430,444 |
| 88,585 |
| 75,652 |
| 75,652 |
| 28.78 |
| 17.58 |
| 95,884 |
| 23,717 |
| 11,234 |
| 108,367 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
430,444 €30 % *
Sales per employee (€)
430,444 €- *
Profit before tax (€)
88,585 €30 % *
Net Profit (€)
75,652 €28 % *
Profit per employee (€)
75,652 €- *
Total profitability (%)
28.78 %-1.47 % *
Net profitability (%)
17.58 %-1.51 % *
Equity (€)
95,884 €60 % *
Amounts Payable And Liabilities (€)
23,717 €31 % *
Non-current Assets (€)
11,234 €27 % *
CurrentAssets (€)
108,367 €57 % *
